Cargando…
Everolimus in Heart Transplantation: An Update
The evidence base relating to the use of everolimus in heart transplantation has expanded considerably in recent years, providing clinically relevant information regarding its use in clinical practice. Unless there are special considerations to take into account, all de novo heart transplant patient...
Autores principales: | Hirt, Stephan W., Bara, Christoph, Barten, Markus J., Deuse, Tobias, Doesch, Andreas O., Kaczmarek, Ingo, Schulz, Uwe, Stypmann, Jörg, Haneya, Assad, Lehmkuhl, Hans B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870122/ https://www.ncbi.nlm.nih.gov/pubmed/24382994 http://dx.doi.org/10.1155/2013/683964 |
Ejemplares similares
-
Thymoglobulin induction in heart transplantation: patient selection and implications for maintenance immunosuppression
por: Zuckermann, Andreas, et al.
Publicado: (2015) -
Efficacy and Safety of Low-Dose Everolimus as Maintenance Immunosuppression in Cardiac Transplant Recipients
por: Fuchs, Uwe, et al.
Publicado: (2012) -
The role of everolimus in liver transplantation
por: Ganschow, Rainer, et al.
Publicado: (2014) -
Everolimus-Induced Immune Effects after Heart Transplantation: A Possible Tool for Clinicians to Monitor Patients at Risk for Transplant Rejection
por: Klaeske, Kristin, et al.
Publicado: (2021) -
Everolimus and Malignancy after Solid Organ Transplantation: A Clinical Update
por: Holdaas, Hallvard, et al.
Publicado: (2016)